Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Akers Biosciences, Inc.    AKER

AKERS BIOSCIENCES, INC.

(AKER)
  Report
SummaryQuotesChartsNewsCompanyFinancials 
Business Summary
Logo Akers Biosciences, Inc.
Akers Biosciences, Inc. develops, manufactures, and supplies point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician. The Company’s product offerings focus on delivering diagnostic assistance in a variety of healthcare fields/specialties, including diagnostic rapid manual point-of-care tests for the detection of allergic reactions to Heparin and for on- and off-the-job alcohol safety initiatives. The Company's primary focus is on the development and sale of disposable diagnostic testing devices that can be performed in minutes, to facilitate time sensitive therapeutic decisions. The Company's main products include a disposable breathalyzer test that measures the blood alcohol content of the user, a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposable breathalyzer test that measures Free Radical activity in the human body.

Number of employees : 12 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Particle ImmunoFiltration Assay1.4285.4%1.3384.2% -6.65%
MicroParticle Catalyzed Biosensor0.1247.4%0.1268% +1.78%
Rapid Enzymatic Assay0.0694.1%0.0855.4% +23.64%
Other0.0513%0.0382.4% -24.52%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
United States1.5894.7%1.5698.9% -1.09%
Rest of World0.0895.3%0.0181.1% -80.29%
Managers and Directors
NameAgeSinceTitle
Christopher C. Schreiber542020President & Chief Executive Officer
Joshua Nathaniel Silverman492020Chairman
Stuart Benson592020Chief Financial Officer
Bill Joe White582017Independent Non-Executive Director
Robert C. Schroeder532019Independent Non-Executive Director
Gary M. Rauch64-Vice President-Finance & Treasurer
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 8,859,868 7,438,205 84.0% 0 0.0% 84.0%
Shareholders
NameEquities%
Iroquois Capital Management LLC 1,040,540 11.7%
Intracoastal Capital LLC 729,729 8.24%
Sabby Capital LLC 299,913 3.39%
Hudson Bay Capital Management LP 240,305 2.71%
Armistice Capital LLC 190,714 2.15%
Anson Funds Management LP 109,500 1.24%
Susquehanna Investment Group LLC 44,583 0.50%
Renaissance Technologies LLC 41,708 0.47%
Candriam Belgium SA 36,146 0.41%
The Vanguard Group, Inc. 35,980 0.41%
Company contact information
Akers Biosciences, Inc.
201 Grove Road
West Deptford, NJ 08086

Phone : +1.856.848.8698
Web : http://www.akersbio.com
Sector Medical Equipment, Supplies & Distribution - NEC